Warner-lambert Company

Surendra C Mehta

Mahdi B Fawzi

Russell U Nesbitt

Suk-Zu Song

Galen W Radebaugh

Kuchi S Murthy

Amal Boctor

Zahra A Rashidbaigi

Hua-pin Huang

An ultra-pure, clear thrombin solution having a high specific activity is described as well as a method of manufacture.

Process for preparing an ultra-pure thrombin preparation

Ultra-pure thrombin preparation

Calcium lactate antibacterial complexes in parenteral dosage forms are provided that are relatively free from tissue irritation following injection, comprising a quinolone or naphthyridine.

Soluble calcium lactate antibacterial complexes as non-irritating

A process for the manufacture of purified thromboplastin used in the manufacture of an ultra-pure, clear thrombin solution is described.

Process for purified thromboplastin for ultra-pure thrombin preparation

A new series of copolymers which are useful as coatings for solid dosage forms, for transdermal devices, for wound dressing materials, and for contact lenses. Also disclosed are methods for preparing monomers and polymers as well as pharmaceutical compositions containing such polymers.

Methylene pyrrolidone copolymers for contact lens and pharmaceutical

Copolymers from n-alkyl-3-alkenylene-2-pyrrolidone

A new series of copolymers such as N-isopropyl-3-methylene-2-pyrrolidone and 2-hydroxyethylmethacrylate which are useful as coatings for solid dosage forms, for transdermal devices, for wound dressing materials, and for contact lenses. Also disclosed are methods for preparing monomers and polymers as well as pharmaceutical compositions containing such polymers.

N-substituted-3-alkylene-2-pyrrolidone compounds

A composition for the transmembranal, including transdermal administration of a pharmaceutical preparation comprising medical grade dimethylsiloxane, a catalyst capable of forming an elastomer, a permeation enhancer and a biologically active material, as well as a device for administering the aforementioned compositions and also a method for administering transdermally to a mammal an effective amount of the aforementioned compositions is herein described.

Silicone elastomer transdermal matrix system

A composition for the transmembranal, including transdermal, administration of a pharmaceutical preparation comprising cross-linked carboxymethylcellulose, an alcohol soluble poly (2-hydroxyethyl) methacrylate), a permeation enhancer, such as a mixture of linoleic acid and propylene glycol, and a biologically active material, as well as a device for administering the aforementioned composition to mammals, and also a method for administering transdermally to a mammal an effective amount of the aforementioned composition.

Growing community of inventors

Randolph, NJ, United States of America

Surendra C Mehta